**Considerations for the Perfect Biomanufacturing Site**
Biomanufacturing refers to the use of biologics—such as cell lines, enzymes, or microorganisms—to produce commercial products. These products span a wide range of industries, from pharmaceuticals to food ingredients.
As demand for biomanufactured products rises, so does the need for specialized factory sites. However, unlike traditional manufacturing facilities, biomanufacturing site selection involves a more targeted strategy. A recent CBRE report highlights three essential factors that companies must consider when identifying ideal biomanufacturing locations.
**1. Labor and Infrastructure**
Biomanufacturing is a labor-intensive and resource-heavy operation. Energy requirements at these facilities can be as much as 14 times higher than those needed in traditional manufacturing operations. Additionally, the wastewater produced from these processes demands advanced treatment systems.
The industry requires a highly skilled workforce, including researchers and manufacturing professionals. Due to the capital-intensive nature of biomanufacturing, location decisions must be data-driven. CBRE stresses a holistic approach that includes evaluating labor cost and availability, energy and water infrastructure, and state and local economic incentives.
**2. Supply Diversification**
The COVID-19 pandemic exposed significant supply chain weaknesses, which continue to disrupt manufacturing operations—including in the biomanufacturing sector. To enhance supply chain resilience and avoid tariffs, many life sciences companies are increasing domestic production of raw and intermediate materials.
This shift is driving the need for more biomanufacturing facilities in the United States, often resulting in simultaneous site searches and the launch of multiple capital projects.
**3. Access to Capital**
Standing up a biomanufacturing site doesn’t only require personnel and infrastructure—it also demands significant capital investment. Many companies opt to own their facilities to protect production capacity and critical equipment.
This ownership model often involves complex financing strategies and significant capital expenditures across numerous projects. Financial flexibility is crucial, and companies may explore a range of funding solutions, including development financing or sale-leaseback agreements, to maintain liquidity and support growth.
In summary, securing the right biomanufacturing site requires careful consideration of infrastructure, labor, supply chain resilience, and financial strategy. As the sector continues to expand, thoughtful and informed site selection will be critical to long-term success.
